Tumor Heterogeneity Selective Pressure – Why We Need New Targets? – Oliver Sartor
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC The Biological Basis of Metastatic Prostate Cancer – The Unmet Medical Need for New Targets and Novel Treatment Pathways – Dan George Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: A. Oliver Sartor, MD, Disease Group Leader GU Cancers, Director of Radiopharmaceutical…